Gene · 7045
Papers3,774
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,774
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of potential drug targets for insomnia by Mendelian randomization analysis based on plasma proteomics. | Front Neurol | 2024 | 38725646 | PubTator, text mining | PubMed |
| Periostin Is a Biomarker for Anterior Shoulder Instability: Proteomic Analysis of Synovial Fluid. | Am J Sports Med | 2024 | 38702960 | PubTator, text mining | PubMed |
| Integrated Analysis Identified TGFBI as a Biomarker of Disease Severity and Prognosis Correlated with Immune Infiltrates in Patients with Sepsis. | J Inflamm Res | 2024 | 38645878 | PubTator, text mining | PubMed |
| Involvement of TGFBI-TAGLN axis in cancer stem cell property of head and neck squamous cell carcinoma. | Sci Rep | 2024 | 38514830 | PubTator, text mining | PubMed |
| Unlocking the potential of senescence-related gene signature as a diagnostic and prognostic biomarker in sepsis: insights from meta-analyses, single-cell RNA sequencing, and in vitro experiments. | Aging (Albany NY) | 2024 | 38412321 | PubTator, text mining | PubMed |
| Novel prognostic marker TGFBI affects the migration and invasion function of ovarian cancer cells and activates the integrin αvβ3-PI3K-Akt signaling pathway. | J Ovarian Res | 2024 | 38395907 | PubTator, text mining | PubMed |
| HIF-2α-dependent TGFBI promotes ovarian cancer chemoresistance by activating PI3K/Akt pathway to inhibit apoptosis and facilitate DNA repair process. | Sci Rep | 2024 | 38365849 | PubTator, text mining | PubMed |
| Endothelial Overexpression of TGF-β-Induced Protein Impairs Venous Thrombus Resolution: Possible Role in CTEPH. | JACC Basic Transl Sci | 2024 | 38362348 | PubTator, text mining | PubMed |
| IC3D Classification of Corneal Dystrophies-Edition 3. | Cornea | 2024 | 38359414 | PubTator, text mining | PubMed |
| Size-exclusion chromatography combined with DIA-MS enables deep proteome profiling of extracellular vesicles from melanoma plasma and serum. | Cell Mol Life Sci | 2024 | 38353833 | PubTator, text mining | PubMed |
| Prioritising genetic findings for drug target identification and validation. | Atherosclerosis | 2024 | 38325120 | PubTator, text mining | PubMed |
| SYT7 (synaptotagmin 7) promotes cervical squamous cell carcinoma. | Heliyon | 2024 | 38314285 | PubTator, text mining | PubMed |
| T-cell infiltration and its regulatory mechanisms in cancers: insights at single-cell resolution. | J Exp Clin Cancer Res | 2024 | 38303018 | PubTator, text mining | PubMed |
| BNIPL is a promising biomarker of laryngeal cancer: novel insights from bioinformatics analysis and experimental validation. | BMC Med Genomics | 2024 | 38302910 | PubTator, text mining | PubMed |
| Unilateral Granular Type 2 Corneal Dystrophy With Exacerbation After LASIK. | Cornea | 2024 | 38300218 | PubTator, text mining | PubMed |
| Cathepsin D promotes polarization of tumor-associated macrophages and metastasis through TGFBI-CCL20 signaling. | Exp Mol Med | 2024 | 38297161 | PubTator, text mining | PubMed |
| Tumor microenvironment of cancer stem cells: Perspectives on cancer stem cell targeting. | Genes Dis | 2024 | 38292177 | PubTator, text mining | PubMed |
| Single-cell landscape of the cellular microenvironment in three different colonic polyp subtypes in children. | Clin Transl Med | 2024 | 38264936 | PubTator, text mining | PubMed |
| Sputum Transcriptomics Reveals FCN1+ Macrophage Activation in Mild Eosinophilic Asthma Compared to Non-Asthmatic Eosinophilic Bronchitis. | Allergy Asthma Immunol Res | 2024 | 38262391 | PubTator, text mining | PubMed |
| Chloride Intracellular Channel Protein 1 (CLIC1) Is a Critical Host Cellular Factor for Influenza A Virus Replication. | Viruses | 2024 | 38257829 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7045/papers?page=11